Literature DB >> 33461040

Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations.

Dmitry Filosofov1, Elena Kurakina2, Valery Radchenko3.   

Abstract

Targeted Auger Therapy represents great potential for the therapy of diseases which require a high degree of selectivity on the cellular level (e.g. for therapy of metastatic cancers). Due to their high Linear Energy Transfer (LET), Auger emitters, combined with selective biological systems which enable delivery of radionuclides close to the DNA of the targeting cell, can be extremely selective and powerful treatment tools. There are two main aspects associated with the development of efficient radiopharmaceuticals based on Auger Emitters: a) the availability of suitable Auger-emitting radionuclides for therapy and b) the design of targeting vectors which can deliver Auger emitters into/close to the nucleus. In the present review, we address the first aspect by defining important parameters for the selection of radionuclides for application to Targeted Auger Therapy and form a categorized list of the most promising radionuclides, their possible production routes, and their use in the synthesis of radiopharmaceuticals.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chelation; Potent candidates; Production; Radiochemistry; Targeted Auger Therapy

Year:  2020        PMID: 33461040     DOI: 10.1016/j.nucmedbio.2020.12.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  6 in total

1.  Development of Novel 191Pt-Labeled Hoechst33258: 191Pt Is More Suitable than 111In for Targeting DNA.

Authors:  Honoka Obata; Atsushi B Tsuji; Katsushi Kumata; Hitomi Sudo; Katsuyuki Minegishi; Kotaro Nagatsu; Hideo Takakura; Mikako Ogawa; Akihiro Kurimasa; Ming-Rong Zhang
Journal:  J Med Chem       Date:  2022-03-31       Impact factor: 8.039

Review 2.  Auger: The future of precision medicine.

Authors:  Giacomo Pirovano; Thomas C Wilson; Thomas Reiner
Journal:  Nucl Med Biol       Date:  2021-03-19       Impact factor: 2.408

3.  Relationship of In Vitro Toxicity of Technetium-99m to Subcellular Localisation and Absorbed Dose.

Authors:  Ines M Costa; Noor Siksek; Alessia Volpe; Francis Man; Katarzyna M Osytek; Elise Verger; Giuseppe Schettino; Gilbert O Fruhwirth; Samantha Y A Terry
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

4.  A Third Generation Potentially Bifunctional Trithiol Chelate, Its nat,1XXSb(III) Complex, and Selective Chelation of Radioantimony (119Sb) from Its Sn Target.

Authors:  Aeli P Olson; Li Ma; Yutian Feng; Firouzeh Najafi Khosroshahi; Steven P Kelley; Eduardo Aluicio-Sarduy; Todd E Barnhart; Heather M Hennkens; Paul A Ellison; Silvia S Jurisson; Jonathan W Engle
Journal:  Inorg Chem       Date:  2021-10-04       Impact factor: 5.165

5.  Synthesis of no-carrier-added [188, 189, 191Pt]cisplatin from a cyclotron produced 188, 189, 191PtCl42- complex.

Authors:  Honoka Obata; Katsuyuki Minegishi; Kotaro Nagatsu; Mikako Ogawa; Ming-Rong Zhang
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

6.  Relevance of Palladium to Radiopharmaceutical Development Considering Enhanced Coordination Properties of TE1PA.

Authors:  Julie Pineau; Luís M P Lima; Carlos Platas-Iglesias; Jan Rijn Zeevaart; Cathryn H S Driver; Nathalie Le Bris; Raphaël Tripier
Journal:  Chemistry       Date:  2022-06-10       Impact factor: 5.020

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.